Amersham to market Optison in Europe

Amersham Health has received European Union approval to market its Optison cardiac ultrasound contrast agent. The London-based firm, which has been marketing Optison in North America since 2000, will begin selling the agent in Europe this month.

By AuntMinnie.com staff writers
June 6, 2002

Related Reading

Amersham inks supply deal with Novation, May 29, 2002

Amersham shows uptick in Q1 numbers, April 29, 2002

Amersham launches online encyclopedia, March 4, 2002

Amersham inks deal with Pfizer, February 1, 2002

Amersham expands radiopharmacy network, January 23, 2002

Copyright © 2002 AuntMinnie.com

Page 1 of 519
Next Page